| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/18/2004 | WO2004022075A1 Treatment of neurological disorders by dsrna adminitration |
| 03/18/2004 | WO2004022072A1 Boronic acid salts ant their use in the treatment of thrombosis |
| 03/18/2004 | WO2004022071A1 Multivalent metal salts of boronic acids for treating thrombosis |
| 03/18/2004 | WO2004022070A1 Boronic acid salts useful in parenteral formulations for selective thrombin inhibition |
| 03/18/2004 | WO2004022059A2 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 03/18/2004 | WO2004022033A1 Method and device for the controlled delivery of parathyroid hormone |
| 03/18/2004 | WO2004022004A2 Modified glp-1 receptor agonists and their pharmacological methods of use |
| 03/18/2004 | WO2004022003A2 Materials and methods for treatment of allergic diseases |
| 03/18/2004 | WO2004022000A2 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 03/18/2004 | WO2004021995A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 03/18/2004 | WO2004021993A2 Modified asialo-interferons and uses thereof |
| 03/18/2004 | WO2004021991A2 Asialo-interferons and the treatment of liver cancer |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021967A2 Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent |
| 03/18/2004 | WO2004021861A2 Targeted release |
| 03/18/2004 | WO2004011487A3 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003105755A3 Antisense modulation of vegf-c expression |
| 03/18/2004 | WO2003105676A3 Compositions and methods for reducing lung volume |
| 03/18/2004 | WO2003100434A3 Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2) |
| 03/18/2004 | WO2003099322A3 Il-11 derivatives and therapeutic uses thereof |
| 03/18/2004 | WO2003092719A3 Methods and compositions for modulating beta-catenin phosphorylation |
| 03/18/2004 | WO2003092684A8 TIME-RESOLVED FLUORESCENCE ASSAY FOR THE DETECTION OF MULTIMERIC FORMS OF A-β[BETA] OR OTHER AGGREGATING POLYPEPTIDES |
| 03/18/2004 | WO2003089459A3 Thyrotropin-releasing hormone analogues and their therapeutic applications |
| 03/18/2004 | WO2003087146A3 Purified polypeptides from s. aureus, h. pylori and e. coli involved in cellular transport and metabolism |
| 03/18/2004 | WO2003087143A3 Human polypeptides having antibacterial activity |
| 03/18/2004 | WO2003081257A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
| 03/18/2004 | WO2003078462A3 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003075944A3 Interferon beta-like molecules for treatment of stroke |
| 03/18/2004 | WO2003070750A3 Rna interference mediated inhibition of hepatitis c virus |
| 03/18/2004 | WO2003069310A3 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
| 03/18/2004 | WO2003068961A3 Method to modify differentiation of pluripotential stem cells |
| 03/18/2004 | WO2003066081A3 Bmp inhibitors for the treatment of spondyloarthropathies |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003063788A3 PTPase INHIBITORS AND METHODS OF USING THE SAME |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003053340A3 Antisense modulation of connective tissue growth factor expression |
| 03/18/2004 | WO2003051272A3 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 03/18/2004 | WO2003048361A3 P55pik |
| 03/18/2004 | WO2003047500A3 Vaccine and method for treatment of motor neurone diseases |
| 03/18/2004 | WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003043652A3 The use of leptin in fertility |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003041725A3 Regulation of cgmp-specific phosphodiesterase 9a |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003035688A3 Targeted thrombosis by tissue factor polypeptides |
| 03/18/2004 | WO2003034986A3 Regulation of mononuclear phagocyte stimulation |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2003032809A3 Modulation of akt-dependent response to prevent restenosis |
| 03/18/2004 | WO2003029814B1 Neuropilin/vegf c/vegfr 3 materials and methods |
| 03/18/2004 | WO2003029279A3 Immunodominant acetylcholine receptor alpha subunit peptide: mhc complexes |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003025195A3 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof |
| 03/18/2004 | WO2003022202A3 Compositions and methods for treatment of cancer |
| 03/18/2004 | WO2003015809A3 Antimicrobial cationic peptides and formulations thereof |
| 03/18/2004 | WO2003007874A3 Anti-tumor activity from reptile serum |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2003006641A3 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002098454A3 Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| 03/18/2004 | WO2002096938A3 Human kunitz-type protease inhibitor |
| 03/18/2004 | WO2002096930A3 Iap binding peptides and assays for identifying compounds that bind iap |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002092020A3 Compositions and methods for modulating bone mineral deposition |
| 03/18/2004 | WO2002090578A3 Methods and means of histone methylation |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002078516A3 Compositions and methods for the therapy and diagnosis of cancer |
| 03/18/2004 | WO2002064816A9 Multiple determinants for metabolic phenotypes |
| 03/18/2004 | WO2002059268A3 Factor ixa: factor viiia interaction and methods therefor |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055036 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 03/18/2004 | US20040055027 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 03/18/2004 | US20040054480 Three dimensional structures and models of Fc receptors and uses thereof |
| 03/18/2004 | US20040054414 Collagen-based materials and methods for augmenting intervertebral discs |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054156 Method and reagent for inhibiting hepatitis B viral replication |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054148 Comprises immunoglobulin which preferentially binds aspartate-specific cysteine proteases (ASCPs) for treating and preventing autoimmune, ischemic and neurodegenerative diseases |
| 03/18/2004 | US20040054147 Novel protein, its gene, reagents for inducing apoptosis, and anticancer agent |
| 03/18/2004 | US20040054146 Allergy vaccines |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054143 Vegf peptides and their use for inhibiting angiogenesis |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054140 Neuronal differentiation regulating factor for treatment of central nervous system disorders |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054138 Hydrolase for diagnosis, preventiong and treatment of eye, nervous system, cardiovascular, cell proliferative and autoimmune/inflammatory disorders |
| 03/18/2004 | US20040054137 Chimeric protein for diagnosis and treatment of cancers and infections; immunotherapy |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 03/18/2004 | US20040054131 Receptor binding amino acid sequences for diagnosis and treatment of tumor and neovascularization disorders |
| 03/18/2004 | US20040054130 Insulin potentiating peptides |
| 03/18/2004 | US20040054129 Novel peptides and compositions which modulate apoptosis |